IER5L is a Prognostic Biomarker in Pan-Cancer Analysis and Correlates with Immune Infiltration and Immune Molecules in Non-Small Cell Lung CancerXin Chen, Qi Zhu|International Journal of General Medicine|2023Cited by 6